论文部分内容阅读
为探讨CD44在卵巢肿瘤组织中的表达及其临床意义。我们采用RNA逆转录-聚合酶链反应（RT-PCR）方法，对卵巢肿瘤及对照组织中的CD44标准型（CD44S幻变异型（CD44V）以及变异型中的一些亚型（CD44V3、V6、V9）的表达进行检测。现报道如下。一、材料与方法1．标本来源及临床资料：
To investigate the expression of CD44 in ovarian tumor and its clinical significance. We used CD44V (CD44V) and some of the variants (CD44V3, V6, V9) in ovarian tumors and control tissues using RNA reverse transcription polymerase chain reaction (RT-PCR) ) Are reported as follows.Report as follows.First, materials and methods 1 specimen source and clinical data: